Skip to main content

Advertisement

Log in

Surgical treatment of sacral chordoma: prognostic variables for local recurrence and overall survival

  • Original Article
  • Published:
European Spine Journal Aims and scope Submit manuscript

Abstract

Purpose

Sacral chordomas (SC) are rare, locally invasive, malignant neoplasms. Despite surgical resection and adjuvant therapies, local recurrence (LR) is common and overall survival (OS) is poor. The objective of this study was to identify prognostic factors that have an impact on the local recurrence-free survival (LRFS) and OS of patients with SC.

Methods

Utilizing the AOSpine Knowledge Forum Tumor multicenter ambispective database, surgically treated SC cases were identified. Cox regression modeling was used to assess the effect of several clinically relevant variables on OS and LRFS.

Results

A total of 167 patients with surgically treated SC were identified. The male/female ratio was 98/69 with a mean age of 57 ± 15 years at the time of surgery. The LR was 35 % (n = 57), death occurred in 30 % of patients (n = 50) during the study period. The median OS was 6 years post-surgery and LRFS was 4 years. In the univariate analysis, previous tumor surgery at the same site (P = 0.002), intralesional resection (P < 0.001), and larger tumor volume (P = 0.030) were significantly associated with LR. Increasing age (P < 0.001) and a preoperative motor deficit of C or D (P = 0.003) were significantly associated with poor OS, and nerve root sacrifice showed a trend towards significance (P = 0.088). In the multivariate models, previous surgery and intralesional resection were significantly related to LR, while increasing age and motor deficit of C or D were associated with poor OS.

Conclusions

This study identified two predictive variables for LRFS (previous tumor surgery and type of surgical resection) and two for OS (age and impaired motor function) in surgically treated SC patients. Our results indicate that en bloc resection reduces LR but does not influence OS. However, this was likely due to short follow-up (3.2 years).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Walcott BP, Nahed BV, Mohyeldin A, Coumans JV, Kahle KT, Ferreira MJ (2012) Chordoma: current concepts, management, and future directions. Lancet Oncol 13(2):e69–e76. doi:10.1016/S1470-2045(11)70337-0

    Article  PubMed  Google Scholar 

  2. Ropper AE, Cahill KS, Hanna JW, McCarthy EF, Gokaslan ZL, Chi JH (2012) Primary vertebral tumors: a review of epidemiologic, histological and imaging findings, part II: locally aggressive and malignant tumors. Neurosurgery 70(1):211–219. doi:10.1227/NEU.0b013e31822d5f17 (discussion 219)

    Article  PubMed  Google Scholar 

  3. Fourney DR, Gokaslan ZL (2003) Current management of sacral chordoma. Neurosurg Focus 15(2):E9

    Article  PubMed  Google Scholar 

  4. Fourney DR, Rhines LD, Hentschel SJ, Skibber JM, Wolinsky JP, Weber KL, Suki D, Gallia GL, Garonzik I, Gokaslan ZL (2005) En bloc resection of primary sacral tumors: classification of surgical approaches and outcome. J Neurosurg Spine 3(2):111–122. doi:10.3171/spi.2005.3.2.0111

    Article  PubMed  Google Scholar 

  5. Hsu W, Kosztowski TA, Zaidi HA, Dorsi M, Gokaslan ZL, Wolinsky JP (2009) Multidisciplinary management of primary tumors of the vertebral column. Curr Treat Options Oncol 10(1–2):107–125. doi:10.1007/s11864-009-0102-8

    Article  PubMed  Google Scholar 

  6. Varga PP, Szövérfi Z, Lazary A (2014) Surgical treatment of primary malignant tumors of the sacrum. Neurol Res 36(6):577–587. doi:10.1179/1743132814Y.0000000366

    Article  PubMed  Google Scholar 

  7. Ahmed AR (2009) Safety margins in resection of sacral chordoma: analysis of 18 patients. Arch Orthop Trauma Surg 129(4):483–487. doi:10.1007/s00402-008-0674-y

    Article  PubMed  Google Scholar 

  8. Hanna SA, Aston WJ, Briggs TW, Cannon SR, Saifuddin A (2008) Sacral chordoma: can local recurrence after sacrectomy be predicted? Clin Orthop Relat Res 466(9):2217–2223. doi:10.1007/s11999-008-0356-7

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. York JE, Kaczaraj A, Abi-Said D, Fuller GN, Skibber JM, Janjan NA, Gokaslan ZL (1999) Sacral chordoma: 40-year experience at a major cancer center. Neurosurgery 44(1):74–79 (discussion 79–80)

  10. Fuchs B, Dickey ID, Yaszemski MJ, Inwards CY, Sim FH (2005) Operative management of sacral chordoma. J Bone Joint Surg Am 87(10):2211–2216. doi:10.2106/JBJS.D.02693

    Article  PubMed  Google Scholar 

  11. Hulen CA, Temple HT, Fox WP, Sama AA, Green BA, Eismont FJ (2006) Oncologic and functional outcome following sacrectomy for sacral chordoma. J Bone Joint Surg Am 88(7):1532–1539. doi:10.2106/JBJS.D.02533

    Article  PubMed  Google Scholar 

  12. Atalar H, Selek H, Yildiz Y, Saglik Y (2006) Management of sacrococcygeal chordomas. Int Orthop 30(6):514–518. doi:10.1007/s00264-006-0095-x

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Baratti D, Gronchi A, Pennacchioli E, Lozza L, Colecchia M, Fiore M, Santinami M (2003) Chordoma: natural history and results in 28 patients treated at a single institution. Ann Surg Oncol 10(3):291–296

    Article  CAS  PubMed  Google Scholar 

  14. Kayani B, Hanna SA, Sewell MD, Saifuddin A, Molloy S, Briggs TW (2014) A review of the surgical management of sacral chordoma. Eur J Surg Oncol. doi:10.1016/j.ejso.2014.04.008

    PubMed  Google Scholar 

  15. Ruggieri P, Angelini A, Ussia G, Montalti M, Mercuri M (2010) Surgical margins and local control in resection of sacral chordomas. Clin Orthop Relat Res 468(11):2939–2947. doi:10.1007/s11999-010-1472-8

    Article  PubMed Central  PubMed  Google Scholar 

  16. McGirt MJ, Gokaslan ZL, Chaichana KL (2011) Preoperative grading scale to predict survival in patients undergoing resection of malignant primary osseous spinal neoplasms. Spine J 11(3):190–196. doi:10.1016/j.spinee.2011.01.013

    Article  PubMed  Google Scholar 

  17. Samson IR, Springfield DS, Suit HD, Mankin HJ (1993) Operative treatment of sacrococcygeal chordoma. A review of twenty-one cases. J Bone Joint Surg Am 75(10):1476–1484

  18. Bergh P, Kindblom LG, Gunterberg B, Remotti F, Ryd W, Meis-Kindblom JM (2000) Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer 88(9):2122–2134

    Article  CAS  PubMed  Google Scholar 

  19. Schwab JH, Healey JH, Rose P, Casas-Ganem J, Boland PJ (2009) The surgical management of sacral chordomas. Spine 34(24):2700–2704. doi:10.1097/BRS.0b013e3181bad11d

    Article  PubMed  Google Scholar 

  20. Cheng EY, Ozerdemoglu RA, Transfeldt EE, Thompson RC Jr (1999) Lumbosacral chordoma. Prognostic factors and treatment. Spine 24(16):1639–1645

    Article  CAS  PubMed  Google Scholar 

  21. Szövérfi Z, Lazary A, Bozsódi Á, Klemencsics I, Éltes PE, Varga PP (2014) Primary spinal tumor mortality score (PSTMS): a novel scoring system for predicting poor survival. Spine J 14(11):2691–2700. doi:10.1016/j.spinee.2014.03.009

    Article  PubMed  Google Scholar 

  22. Boriani S, Saravanja D, Yamada Y, Varga PP, Biagini R, Fisher CG (2009) Challenges of local recurrence and cure in low grade malignant tumors of the spine. Spine 34(22 Suppl):S48–S57. doi:10.1097/BRS.0b013e3181b969ac

    Article  PubMed  Google Scholar 

  23. Fisher CG, Goldschlager T, Boriani S, Varga PP, Fehlings MG, Bilsky MH, Dekutoski MB, Luzzati A, Williams RP, Berven S, Chou D, Reynolds JJ, Quraishi NA, Rhines LD, Bettegowda C, Gokaslan ZL (2013) A novel scientific model for rare and often neglected neoplastic conditions. Evid-Based Spine-Care J 4(2):160–162. doi:10.1055/s-0033-1357365

    Article  PubMed Central  PubMed  Google Scholar 

  24. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370(9596):1453–1457. doi:10.1016/S0140-6736(07)61602-X

    Article  Google Scholar 

  25. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377–381. doi:10.1016/j.jbi.2008.08.010

    Article  PubMed Central  PubMed  Google Scholar 

  26. Enneking WF, Spanier SS, Goodman MA (1980) A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 153:106–120

    PubMed  Google Scholar 

  27. Fisher CG, Saravanja DD, Dvorak MF, Rampersaud YR, Clarkson PW, Hurlbert J, Fox R, Zhang H, Lewis S, Riaz S, Ferguson PC, Boyd MC (2011) Surgical management of primary bone tumors of the spine: validation of an approach to enhance cure and reduce local recurrence. Spine 36(10):830–836. doi:10.1097/BRS.0b013e3181e502e5

    Article  PubMed  Google Scholar 

  28. Ruggieri P, Angelini A, Pala E, Mercuri M (2012) Infections in surgery of primary tumors of the sacrum. Spine 37(5):420–428. doi:10.1097/BRS.0b013e3182213a44

    Article  PubMed  Google Scholar 

  29. Tokuhashi Y, Matsuzaki H, Toriyama S, Kawano H, Ohsaka S (1990) Scoring system for the preoperative evaluation of metastatic spine tumor prognosis. Spine 15(11):1110–1113

    Article  CAS  PubMed  Google Scholar 

  30. Treatment of spinal metastases and MSCC (2008) In: NICE Clinical Guidelines, No. 75. Metastatic spinal cord compression: diagnosis and management of patients at risk of or with metastatic spinal cord compression National Institute for Health and Clinical Excellence: Guidance, Cardiff, p 29

  31. Peduzzi P, Concato J, Feinstein AR, Holford TR (1995) Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol 48(12):1503–1510

    Article  CAS  PubMed  Google Scholar 

  32. Smoll NR, Gautschi OP, Radovanovic I, Schaller K, Weber DC (2013) Incidence and relative survival of chordomas: the standardized mortality ratio and the impact of chordomas on a population. Cancer 119(11):2029–2037. doi:10.1002/cncr.28032

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We are grateful to the collaborating centers’ local clinical research personnel and support staff for their active participation. This study was organized and funded by AOSpine International, through the AOSpine Knowledge Forum Tumor, a pathology-focused working group of up to ten international spine experts acting on behalf of AOSpine in the domain of scientific expertise. Study support was provided directly through AOSpine’s Research department and AO’s Clinical Investigation and Documentation unit.

Conflict of interest

The authors have no financial conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Péter Pál Varga.

Additional information

P. P. Varga and Z. Szövérfi are co-first authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Varga, P.P., Szövérfi, Z., Fisher, C.G. et al. Surgical treatment of sacral chordoma: prognostic variables for local recurrence and overall survival. Eur Spine J 24, 1092–1101 (2015). https://doi.org/10.1007/s00586-014-3728-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00586-014-3728-6

Keywords

Navigation